X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
diabetes (13) 13
female (13) 13
male (12) 12
cardiac & cardiovascular systems (11) 11
diabetes mellitus, type 2 - drug therapy (11) 11
middle aged (11) 11
aged (9) 9
cardiovascular disease (9) 9
hypoglycemic agents - therapeutic use (9) 9
index medicus (9) 9
risk factors (9) 9
abridged index medicus (8) 8
cardiovascular (8) 8
glucose (8) 8
type 2 diabetes (8) 8
diabetes mellitus, type 2 - blood (7) 7
diabetes mellitus, type 2 - complications (7) 7
double-blind method (7) 7
cardiovascular diseases (6) 6
cardiovascular diseases - prevention & control (6) 6
mortality (6) 6
cardiovascular diseases - epidemiology (5) 5
clinical trials (5) 5
heart attack (5) 5
hypoglycemic agents - administration & dosage (5) 5
prevention (5) 5
blood glucose - metabolism (4) 4
cardiovascular diseases - etiology (4) 4
care and treatment (4) 4
dextrose (4) 4
diabetes therapy (4) 4
endocrinology & metabolism (4) 4
glucose metabolism (4) 4
heart attacks (4) 4
hypoglycemic agents (4) 4
incidence (4) 4
mellitus (4) 4
patients (4) 4
studies (4) 4
administration, oral (3) 3
adult (3) 3
blood pressure (3) 3
cardiac patients (3) 3
cardiovascular diseases - mortality (3) 3
diabetes mellitus (3) 3
disease (3) 3
drug therapy (3) 3
family medical history (3) 3
glucose tolerance test (3) 3
heart failure (3) 3
heart-failure (3) 3
insulin - therapeutic use (3) 3
medicine, general & internal (3) 3
metaanalysis (3) 3
metformin (3) 3
myocardial infarction - prevention & control (3) 3
nateglinide (3) 3
patient outcomes (3) 3
prospective studies (3) 3
research design (3) 3
risk (3) 3
stroke - prevention & control (3) 3
sulfonylurea compounds - therapeutic use (3) 3
tetrazoles - therapeutic use (3) 3
valine - analogs & derivatives (3) 3
valine - therapeutic use (3) 3
valsartan (3) 3
acarbose (2) 2
aged, 80 and over (2) 2
all-cause mortality (2) 2
analysis (2) 2
angiotensin ii type 1 receptor blockers - therapeutic use (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
association (2) 2
blood glucose - analysis (2) 2
body mass index (2) 2
cholesterol, hdl - blood (2) 2
clinical-trials (2) 2
coronary-artery-disease (2) 2
cyclohexanes - therapeutic use (2) 2
diabetes-mellitus (2) 2
diabetic angiopathies - prevention & control (2) 2
disease prevention (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
evaluation (2) 2
events (2) 2
exercise (2) 2
fda approval (2) 2
glucagon (2) 2
glucagon-like peptide 1 (2) 2
glucose tolerance tests (2) 2
glycated hemoglobin a - metabolism (2) 2
health risk assessment (2) 2
heart (2) 2
hypertension (2) 2
hypoglycemic agents - adverse effects (2) 2
incretin-based therapies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9922, pp. 1059 - 1066
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 6, pp. 983 - 989.e7
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 103 - 110
Exenatide once-weekly is an extended release formulation of exenatide, a glucagon-like peptide–1 receptor agonist, which can improve glycemic control, body... 
Cardiovascular | DIABETES-MELLITUS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | GLUCAGON-LIKE PEPTIDE-1 | MYOCARDIAL-INFARCTION | SAFETY | RECEPTOR AGONISTS | GLUCOSE | CLINICAL-TRIALS | DISEASE | INCRETIN-BASED THERAPIES | Risk Assessment - methods | United States - epidemiology | Glucagon-Like Peptide 1 | Prognosis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Peptides - administration & dosage | Incidence | Dose-Response Relationship, Drug | Microspheres | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Cardiovascular Diseases - etiology | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Factors | China - epidemiology | Diabetes Mellitus, Type 2 - blood | Ontario - epidemiology | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Hypoglycemic agents | Glucagon | Cardiac patients | Heart attack | Corporate sponsorship | Heart attacks | Research & development--R&D | Pragmatism | Cardiovascular disease | Diabetes | Pharmaceutical industry | Patients | Cholesterol
Journal Article
American Heart Journal, ISSN 0002-8703, 2008, Volume 156, Issue 4, pp. 623 - 632
Patients with impaired glucose tolerance (IGT) have increased risk for developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Lifestyle... 
Cardiovascular | PATHOGENESIS | AMLODIPINE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | LEFT-VENTRICULAR DYSFUNCTION | CLINICAL-TRIAL | REDUCTION | RISK | MELLITUS | PREVALENCE | HYPERTENSION | Hypoglycemic Agents - therapeutic use | Life Style | Double-Blind Method | Outcome Assessment (Health Care) | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Valine - analogs & derivatives | Diabetic Angiopathies - drug therapy | Disease Progression | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Diabetic Angiopathies - physiopathology | Glucose Intolerance - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Tetrazoles - therapeutic use | Valine - therapeutic use | Diabetic Angiopathies - prevention & control | Phenylalanine - therapeutic use | Research Design | Nateglinide | Type 2 diabetes | Heart failure | Care and treatment | Patient outcomes | Clinical trials | Dietary fat | Research | Glucose | Glucose tolerance tests | Heart attack | Dextrose | Prevention | Hyperglycemia | Coronary artery bypass | Cardiac patients | Diabetes | Cardiology | Studies | Disease prevention | Stroke | Heart attacks | Heart surgery | Mortality | Electrocardiography | Cardiovascular disease | Blood pressure | Risk factors
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 5, pp. 935 - 940.e1
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 187, pp. 1 - 9
Journal Article
Diabetes Care, ISSN 0149-5992, 10/2007, Volume 30, Issue 10, pp. 2553 - 2558
Costs of the Metabolic Syndrome in Elderly Individuals Findings from the Cardiovascular Health Study * Lesley H. Curtis , PHD 1 2 , Bradley G. Hammill , MS 1 ,... 
DEFINITION | EVENTS | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | PREVALENCE | ASSOCIATION | PREDICTION
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2013, Volume 36, Issue 6, pp. 1483 - 1488
OBJECTIVE-To assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community... 
COST | GESTATIONAL DIABETES-MELLITUS | AGREEMENT | ASSOCIATION | ENDOCRINOLOGY & METABOLISM | Glucose Tolerance Test | Self Administration | Humans | Middle Aged | Female | Male | Aged | Glucose metabolism | Nurses | Analysis | Glucose | Pharmaceutical industry | Glucose tolerance tests | Dextrose | Nutrition research | Biomedical research | Diabetes | Medical screening | Public health | Original Research
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 01/2008, Volume 24, Issue 1, pp. 41 - 50
Objective: To explore relationships between β-cell function and incident cardiovascular events, death, and medical costs among elderly individuals.Research... 
MORTALITY | INSULIN-SECRETING CELLS | HEALTHCARE COSTS | CORONARY DISEASE
Journal Article